ArticleJBRA assisted reproduction2025
Chemically defined 3D matrix for in vitro maturation (IVM) of human oocytes.
Article in JBRA assisted reproduction, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveImprovements in oocyte culture conditions may enhance oocyte maturation rates. PVA has been used in tissue engineering scaffolds to provide suitable strength and adhesive properties to support cell adhesion and proliferation. The aim of the present study was to test a three-dimensional PVA matrix for human rescue oocyte maturation.
methodsImmature human oocytes and cumulus cells were obtained from patients undergoing conventional IVF cycles. Firstly, two replicates of cumulus cells exposed to PVA-BTCA matrices were performed to assess a possible cytotoxic effect of the matrix. Next, a total of 23 immature oocytes and respective cumulus cells were split between the control and PVA-BTCA-containing culture system for rescue IVM, at 38oC and 5%CO2.
resultsCumulus cells exposure to PVA matrix allows for cell survival and adhesion to the substrate, confirming its non-toxicity. The overall maturation rate in the PVA-BTCA culture system was 66.6% (n=10/15): 77.7% of VG (n=7/9) and 50% (n=3/6) of MI oocytes reached MII. The control culture received 8 VG oocytes, of which 37.5% (n=3) reached MI and 62.5% reached MII (n=5).
conclusionsPVA-BTCA-containing culture system may represent an alternative for human oocyte maturation procedures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.